A SPAC III Acquisition Corp.
ASPCR
NASDAQ Capital Market0.10
USD
-0.05
- -
CIK
0001890361
ISIN
VGG0544A1451
Return %
Stock
S&P500
1Y
-49.95
26.53
3Y
-19.92
76.60
5Y
-19.92
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Sze Wai Tsang
- Full Time Employees
- 1
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- The Sun’s Group Center Hong Kong Hong Kong
- IPO Date
- Nov 8, 2024
- CIK
- 0001890361
- Website
- spacresearch.com
- Similar Companies
- Business
- A SPAC III Acquisition Corp. (NASDAQ: ASPC, ASPCU, ASPCR) is a blank check company, also known as a special purpose acquisition company, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses; it currently has no significant operations and focuses primarily on identifying and pursuing prospective targets in the environmental, sustainability and governance (ESG) and material technology sectors with enterprise values between $100 million and $600 million. The company offers investors exposure to its Class A ordinary shares, rights (entitling holders to one-tenth of one Class A ordinary share upon consummation of an initial business combination), and units comprising both, traded on the Nasdaq Capital Market. Founded in 2021 and headquartered at The Sun’s Group Center, 29th Floor, 200 Gloucester Road, Wan Chai, Hong Kong, it operates as a British Virgin Islands exempted company targeting opportunities primarily in Greater China and emerging markets, led by CEO and Chairman Claudius Tsang with extensive experience in private equity and M&A. In November 2024, A SPAC III Acquisition Corp. completed a $55 million initial public offering of 5.5 million units at $10.00 per unit, managed by Maxim Group LLC as sole book-runner, with an over-allotment option for up to 825,000 additional units; units began trading under ASPCU on November 8, 2024, followed by separate trading of shares (ASPC) and rights (ASPCR) commencing January 3, 2025. On May 23, 2025, the company entered into a merger agreement with Bioserica International Limited, a bio-based antimicrobial materials developer that researches, manufactures, markets, and sells such products through subsidiaries including Bioserica Hong Kong and Bioserica (Nanjing) Antimicrobial Material Co., Ltd., for total consideration of $200 million payable in stock (primarily newly issued Class B ordinary shares of the post-merger entity at $10.00 per share, plus up to 1,786,000 Class A ordinary shares); the transaction, structured as a reverse merger involving a reincorporation merger and acquisition merger, remains pending shareholder approval, regulatory clearances, and definitive agreements following termination of a prior non-binding indication of interest with HDEducation Group Limited on May 21, 2025. Shareholders approved a charter amendment on October 27, 2025, extending the business combination deadline from November 12, 2025, to November 12, 2026, with significant redemptions of 5,717,419 ordinary shares.